GBA1 and Parkinson disease: PD patients with biallelic GBA variants (either homozygous or compound heterozygous), hereafter referred to as GD-PD, also have an earlier age at onset compared with heterozygous carriers (11, 27), indicating a possible “dose” effect of GBA influencing age at onset.